I am working on a bill with Senator Grassley, the Pharmacy Benefit Manager Transparency Act, which would shine a light on bad PBM practices.

I am leading a bill with Senator Grassley, the Pharmacy Benefit Manager Transparency Act, which would crack down on PBM's opaque rebate practices.

People care a whole lot about this matter of getting mugged at the pharmacy counter.

Your bill with Senator Grassley should make it more difficult for PBMs to hide profits from regulators.

I'm proud to say that this is a hearing with strong bipartisan interest, and Senator Crapo and I have agreed to take on this issue together.

Taxpayers, seniors facing a 2,000-percent markup.

Every drug should have a price that is available for all to see and creates equity.

In my view, that's a clear example of the perverse incentives PBMs have created that leave so many Americans fed up and outraged at the health-care system in this country.

The average price that PBMs charge Medicare Part D plans for the exact same drug is over $3,000.

Our bipartisan efforts on organ transplants--thank you very much, Senator Grassley--have really paid off.

I am going to go out and have all these town hall meetings, and I am going to hold that up.

That means looking at pharmacy benefit manager practices with a thorough eye and taking any legislative steps necessary to ensure taxpayers and patients aren't getting a raw deal.

The Pharmacy Benefit Manager Transparency Act of 2023 would make material improvements to the transparency of the U.S. health-care system.

I am working on a bill with Senator Grassley, the Pharmacy Benefit Manager Transparency Act, which would shine a light on bad PBM practices.

It undermines the negotiation entirely.

Civica cannot get the big three PBMs to cover the drug.

I'm proud to say that this is a hearing with strong bipartisan interest, and Senator Crapo and I have agreed to take on this issue together.

That is why I previously cosponsored something called Creating Transparency to Have Drug Rebates Unlocked.